Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3

D. Damgaard, M. Bawadekar, L. Senolt, A. Stensballe, MA. Shelef, CH. Nielsen,

. 2018 ; 13 (8) : e0203214. [pub] 20180830

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

OBJECTIVE: Peptidylarginine deiminase 2 (PAD2) and PAD4 are expressed in the synovium of rheumatoid arthritis (RA) patients and catalyze citrullination of arginine residues in proteins targeted by anti-citrullinated protein antibodies (ACPAs). Little is known about the relative importance of PAD2 and PAD4 in generating citrullinated self-antigens. Here we investigate the ability of PAD2 and PAD4 to generate citrullinated targets for ACPAs in four human proteins. METHODS: Synovial fluid (SF) and plasma were collected from 42 RA patients. Human fibrinogen, human alpha-enolase (ENO1), human histone H3, and human serum albumin (HSA) were citrullinated in vitro by PAD2 or PAD4. The total degree of citrullination was determined using the anti-modified citrulline approach. Antibody binding to native and citrullinated proteins was measured by ELISA. RESULTS: ACPAs within pooled SF from multiple RA patients reacted equally well with, and cross-reacted with, PAD2- and PAD4-citrullinated fibrinogen. ACPAs from most individual patient SF and plasma samples bound equally well to PAD2- and PAD4-citrullinated fibrinogen or ENO1. When histone H3 was used as target, PAD4 was generally superior in generating epitopes recognized by ACPAs. No binding to citrullinated HSA was observed. CONCLUSION: In most patients, PAD2 and PAD4 are equally efficient in generating citrullinated target sites for ACPAs in fibrinogen and ENO1. The binding of autoantibodies to histone H3 was generally higher after citrullination with PAD4 than with PAD2. Citrullinated HSA is not a target for ACPAs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012422
003      
CZ-PrNML
005      
20190409160400.0
007      
ta
008      
190405s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0203214 $2 doi
035    __
$a (PubMed)30161253
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Damgaard, Dres $u Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
245    10
$a Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3 / $c D. Damgaard, M. Bawadekar, L. Senolt, A. Stensballe, MA. Shelef, CH. Nielsen,
520    9_
$a OBJECTIVE: Peptidylarginine deiminase 2 (PAD2) and PAD4 are expressed in the synovium of rheumatoid arthritis (RA) patients and catalyze citrullination of arginine residues in proteins targeted by anti-citrullinated protein antibodies (ACPAs). Little is known about the relative importance of PAD2 and PAD4 in generating citrullinated self-antigens. Here we investigate the ability of PAD2 and PAD4 to generate citrullinated targets for ACPAs in four human proteins. METHODS: Synovial fluid (SF) and plasma were collected from 42 RA patients. Human fibrinogen, human alpha-enolase (ENO1), human histone H3, and human serum albumin (HSA) were citrullinated in vitro by PAD2 or PAD4. The total degree of citrullination was determined using the anti-modified citrulline approach. Antibody binding to native and citrullinated proteins was measured by ELISA. RESULTS: ACPAs within pooled SF from multiple RA patients reacted equally well with, and cross-reacted with, PAD2- and PAD4-citrullinated fibrinogen. ACPAs from most individual patient SF and plasma samples bound equally well to PAD2- and PAD4-citrullinated fibrinogen or ENO1. When histone H3 was used as target, PAD4 was generally superior in generating epitopes recognized by ACPAs. No binding to citrullinated HSA was observed. CONCLUSION: In most patients, PAD2 and PAD4 are equally efficient in generating citrullinated target sites for ACPAs in fibrinogen and ENO1. The binding of autoantibodies to histone H3 was generally higher after citrullination with PAD4 than with PAD2. Citrullinated HSA is not a target for ACPAs.
650    _2
$a protilátky proti citrulinovaným peptidům $x metabolismus $7 D000075422
650    _2
$a revmatoidní artritida $x enzymologie $x imunologie $7 D001172
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a citrulinace $7 D000076302
650    _2
$a fibrinogen $x imunologie $7 D005340
650    _2
$a histony $x imunologie $7 D006657
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a techniky in vitro $7 D066298
650    _2
$a fosfopyruváthydratasa $x imunologie $7 D010751
650    _2
$a peptidylarginindeiminasy $x metabolismus $7 D000076342
650    _2
$a rekombinantní proteiny $x metabolismus $7 D011994
650    _2
$a sérový albumin $x imunologie $7 D012709
650    _2
$a synoviální tekutina $7 D013582
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bawadekar, Mandar $u Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
700    1_
$a Senolt, Ladislav $u Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Stensballe, Allan $u Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
700    1_
$a Shelef, Miriam A $u Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America. William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, United States of America.
700    1_
$a Nielsen, Claus H $u Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 13, č. 8 (2018), s. e0203214
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30161253 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190409160415 $b ABA008
999    __
$a ok $b bmc $g 1391732 $s 1050727
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 13 $c 8 $d e0203214 $e 20180830 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20190405

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...